...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Re: TNBC no longer active?
4
Jun 27, 2023 05:05PM
2
Jun 28, 2023 12:10AM
3
Jun 28, 2023 12:37PM
4
Jun 28, 2023 04:32PM
4
Jun 29, 2023 11:24AM
6
Jun 29, 2023 02:16PM
3
Jun 29, 2023 03:19PM

"FDA will no longer accept a phase 2 as registration enabling."

Can't see the FDA standing in the way of a free market economy.

jonzobot: I asked Chris (IR) to expand on Don's comment (made at the AGM) about why Zenith is no longer pursuing TNBC with ZEN-3694 because someone got there first. 

 

Koo 

6
Jun 30, 2023 08:23AM
6
Jun 30, 2023 11:15AM
4
Jul 01, 2023 09:28PM
4
Jul 02, 2023 12:30PM
Share
New Message
Please login to post a reply